Abstract Background: Type 2 diabetes mellitus is a global health challenge associated with significant metabolic and cardiovascular risks. The Triglyceride-Glucose (TyG) index, a marker of insulin resistance and metabolic risk, has gained prominence as a tool to assess the interplay between glycemic control and lipid metabolism. Understanding its association with HbA1c levels may provide insights into better managing patients with type 2 diabetes. Objectives: To assess HbA1c levels and lipid profiles in patients with type 2 diabetes mellitus, calculate the Triglyceride-Glucose (TyG) index, and study the association between the TyG index and HbA1c levels. Methods: A cross-sectional study was conducted over 12 months, involving 50 patients with type 2 diabetes mellitus. Participants were aged above 18 years and diagnosed per ADA criteria. Following written informed consent, a detailed history, clinical examination, and laboratory investigations, including FBS, PPBS, HbA1c, lipid profile, RFT, and LFT, were conducted. Patients were categorized based on HbA1c levels (≤7.0% and >7.0%), and the TyG index was calculated using the formula: log (fasting triglycerides) * (fasting plasma glucose) / 2. Statistical analysis was performed using SPSS Version 26.0, with a significance level of α = 0.05. Results: The mean age of participants was 54.26 years (SD = 7.82). The mean FBS and triglyceride levels were 137.10 mg/dL (SD = 49.47) and 179.36 mg/dL (SD = 94.42), respectively, while the mean HbA1c was 8.62% (SD = 2.52), indicating poor glycemic control in many patients. Nearly 46% of participants had HbA1c levels above 8%. The TyG ratio demonstrated a significant increase with rising HbA1c levels, from a mean of 4.5980 in the 10% group (p < 0.001). Hypertriglyceridemia was strongly associated with poor glycemic control (p < 0.001), while other lipid parameters showed minimal changes. Conclusion: This study established a significant association between the Triglyceride-Glucose (TyG) index and HbA1c levels, emphasizing the role of metabolic dysregulation in poorly managed type 2 diabetes. These findings underscore the importance of effective glycemic control to mitigate metabolic and cardiovascular risks in this population.
International Journal of Medical Science and Advanced Clinical Research (IJMACR) (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: